Hematological Malignancies

Clinical research is centered on blood cancers, with attention to advanced and relapsed or refractory disease. The therapeutic scope includes acute myeloid leukemia, acute lymphoblastic leukemia, diffuse large B-cell lymphoma, multiple myeloma, and high-risk myelodysplastic syndromes.

• Acute myeloid leukemia
• Acute lymphoblastic leukemia
• Diffuse large B-cell lymphoma
• Multiple myeloma
• High-risk myelodysplastic syndromes

Research activity also extends to combination treatment approaches in relapsed/refractory hematologic cancer, reflecting interest in difficult-to-treat malignant disorders of the blood and lymphatic system.